Published in Mol Vis on May 19, 2010
Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol (2012) 2.23
Dry eye as a mucosal autoimmune disease. Int Rev Immunol (2013) 1.85
A method to extract cytokines and matrix metalloproteinases from Schirmer strips and analyze using Luminex. Mol Vis (2011) 1.52
Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res (2012) 1.32
Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture. Am J Ophthalmol (2011) 1.18
Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders. Clin Interv Aging (2013) 1.12
Role of NFAT5 in inflammatory disorders associated with osmotic stress. Curr Genomics (2010) 1.10
A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction. Clin Interv Aging (2013) 1.07
Progress in corneal wound healing. Prog Retin Eye Res (2015) 1.02
Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids. Clin Interv Aging (2013) 1.01
Interferon-γ-secreting NK cells promote induction of dry eye disease. J Leukoc Biol (2011) 1.00
Dry eye disease: A review of diagnostic approaches and treatments. Saudi J Ophthalmol (2014) 0.98
The core mechanism of dry eye disease is inflammation. Eye Contact Lens (2014) 0.98
T helper cytokines in dry eye disease. Exp Eye Res (2013) 0.97
Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy. Graefes Arch Clin Exp Ophthalmol (2011) 0.93
Dry eye disease and microbial keratitis: is there a connection? Ocul Surf (2013) 0.92
Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy. Clin Ophthalmol (2014) 0.89
Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures. Invest Ophthalmol Vis Sci (2013) 0.87
Oxidative stress and its downstream signaling in aging eyes. Clin Interv Aging (2014) 0.85
Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease. Clin Ophthalmol (2016) 0.84
The role and treatment of inflammation in dry eye disease. Int Ophthalmol (2014) 0.84
Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress. Curr Eye Res (2014) 0.84
Ocular side effects of biological agents in oncology: what should the clinician be aware of? Onco Targets Ther (2013) 0.82
Ocular neuropathic pain. Br J Ophthalmol (2015) 0.82
Blueberry Component Pterostilbene Protects Corneal Epithelial Cells from Inflammation via Anti-oxidative Pathway. Sci Rep (2016) 0.82
New testing options for diagnosing and grading dry eye disease. Am J Ophthalmol (2014) 0.81
No consequences of dietary n-3 polyunsaturated fatty acid deficiency on the severity of scopolamine-induced dry eye. Graefes Arch Clin Exp Ophthalmol (2010) 0.79
Abnormal activity of corneal cold thermoreceptors underlies the unpleasant sensations in dry eye disease. Pain (2016) 0.79
The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research. Invest Ophthalmol Vis Sci (2017) 0.78
Changes in cytokines in tears after endoscopic endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction. Eye (Lond) (2014) 0.78
Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine. EPMA J (2016) 0.78
Ocular Surface and Tear Film Changes in Older Women Working with Computers. Biomed Res Int (2015) 0.78
Hyaluronan receptors in the human ocular surface: a descriptive and comparative study of RHAMM and CD44 in tissues, cell lines and freshly collected samples. Histochem Cell Biol (2011) 0.77
Surfactant protein D contributes to ocular defense against Pseudomonas aeruginosa in a murine model of dry eye disease. PLoS One (2013) 0.77
Efficiency and safety of subconjunctival injection of anti-VEGF agent - bevacizumab - in treating dry eye. Drug Des Devel Ther (2015) 0.77
Osmoprotective effects of supplemental epidermal growth factor in an ex vivo multilayered human conjunctival model under hyperosmotic stress. Graefes Arch Clin Exp Ophthalmol (2013) 0.77
Tear cytokine response to multipurpose solutions for contact lenses. Clin Ophthalmol (2013) 0.77
Practical issues concerning tear protein assays in dry eye. Eye Vis (Lond) (2014) 0.76
Cytokine changes in tears and relationship to contact lens discomfort. Mol Vis (2015) 0.76
Immunomodulation on the ocular surface: a review. Cent Eur J Immunol (2016) 0.76
Do Cyclosporine A, an IL-1 Receptor Antagonist, Uridine Triphosphate, Rebamipide, and/or Bimatoprost Regulate Human Meibomian Gland Epithelial Cells? Invest Ophthalmol Vis Sci (2016) 0.76
Analysis of tear inflammatory mediators: A comparison between the microarray and Luminex methods. Mol Vis (2016) 0.76
Effects of chondrocyte-derived extracellular matrix in a dry eye mouse model. Mol Vis (2015) 0.76
Effects of Lutein on Hyperosmoticity-Induced Upregulation of IL-6 in Cultured Corneal Epithelial Cells and Its Relevant Signal Pathways. J Ophthalmol (2016) 0.75
Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye. Clin Ophthalmol (2016) 0.75
Interferon-gamma deficiency protects against aging-related goblet cell loss. Oncotarget (2016) 0.75
Lower Vitamin D Level and Distinct Tear Cytokine Profile Were Observed in Patients with Mild Dry Eye Signs but Exaggerated Symptoms. Transl Vis Sci Technol (2016) 0.75
Human tear analysis with miniaturized multiplex cytokine assay on "wall-less" 96-well plate. Mol Vis (2015) 0.75
Lifitegrast: A novel drug for treatment of dry eye disease. J Pharmacol Pharmacother (2017) 0.75
Discordant Dry Eye Disease (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc (2016) 0.75
Interleukin-1β and tumour necrosis factor-α levels in conjunctiva of diabetic patients with symptomatic moderate dry eye: case-control study. BMJ Open (2016) 0.75
Differences in Dry Eye Questionnaire Symptoms in Two Different Modalities of Contact Lens Wear: Silicone-Hydrogel in Daily Wear Basis and Overnight Orthokeratology. Biomed Res Int (2016) 0.75
Changes in Tear Cytokine Concentrations Following Discontinuation of Soft Contact Lenses-A Pilot Study. Eye Contact Lens (2016) 0.75
Serum Th1 and Th17 related cytokines and autoantibodies in patients with Posner-Schlossman syndrome. PLoS One (2017) 0.75
Conjunctival Goblet Cell Function: Effect of Contact Lens Wear and Cytokines. Eye Contact Lens (2016) 0.75
Effects of silk fibroin in murine dry eye. Sci Rep (2017) 0.75
Effect of trapping vascular endothelial growth factor-A in a murine model of dry eye with inflammatory neovascularization. Int J Ophthalmol (2016) 0.75
Effects of Aging in Dry Eye. Int Ophthalmol Clin (2017) 0.75
Short-term effects of topical cyclosporine A 0.05% (Restasis) in long-standing prosthetic eye wearers: a pilot study. Eye (Lond) (2014) 0.75
Tear fluid signs associated with filtration blebs, as demonstrated by three-dimensional anterior segment optical coherence tomography. Clin Ophthalmol (2014) 0.75
Investigating the Association between Angiogenic Cytokines and Corneal Neovascularization in Sulfur Mustard Intoxicated Subjects 26 Years after Exposure. Toxicol Int (2015) 0.75
Intense pulsed light for evaporative dry eye disease. Clin Ophthalmol (2017) 0.75
The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research. Ophthalmology (2017) 0.75
Tolerability of Topical Tocilizumab Eyedrops in Dogs: A Pilot Study. J Ocul Pharmacol Ther (2017) 0.75
The biology of VEGF and its receptors. Nat Med (2003) 32.13
The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf (2007) 11.76
Interleukin-1 and interleukin-1 antagonism. Blood (1991) 7.67
Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J (1995) 5.36
Diagnostic tests in the Sicca syndrome. Arch Ophthalmol (1969) 4.91
Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol (2007) 3.96
Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol (1998) 3.78
Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci (2001) 3.72
Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf (2007) 3.68
Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea (2006) 3.18
Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea (2003) 2.84
Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res (1999) 2.75
IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol (2009) 2.65
The lack of association between signs and symptoms in patients with dry eye disease. Cornea (2004) 2.61
Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol (2008) 2.37
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 2.21
A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci (2004) 2.14
Classification of chronic blepharitis. Ophthalmology (1982) 1.97
Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea (2009) 1.96
Impaired functional visual acuity of dry eye patients. Am J Ophthalmol (2002) 1.94
The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem (2000) 1.86
Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci (2006) 1.82
Expression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: effects of desiccating stress. Invest Ophthalmol Vis Sci (2007) 1.78
The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci (2005) 1.75
Formation and rupture of the tear film. Exp Eye Res (1973) 1.64
Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes (1999) 1.60
Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf (2009) 1.55
Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma. Am J Respir Crit Care Med (2004) 1.53
Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J Biol Chem (2002) 1.46
Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea (2007) 1.46
Diagnosis of dry eye. Surv Ophthalmol (2001) 1.39
Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eye. Health Qual Life Outcomes (2004) 1.35
The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci (2003) 1.34
Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis. Am J Kidney Dis (2007) 1.34
Inflammatory markers in the tears of patients with ocular surface disease. Ophthalmic Res (2008) 1.33
Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. J Allergy Clin Immunol (2001) 1.30
Sjögren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci (1994) 1.26
Mode of action of cytokines on nociceptive neurons. Exp Brain Res (2009) 1.26
Upregulation of IL-6, IL-8 and CCL2 gene expression after acute inflammation: Correlation to clinical pain. Pain (2009) 1.19
The importance of the precorneal tear film for the quality of optical imaging. Br J Ophthalmol (1992) 1.16
Elevated tear interleukin-6 levels in patients with Sjögren syndrome. Ophthalmology (1998) 1.16
Conjunctival cytokine expression in symptomatic moderate dry eye subjects. Invest Ophthalmol Vis Sci (2006) 1.15
Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention. Mediators Inflamm (2009) 1.14
The contribution of lipid layer movement to tear film thinning and breakup. Invest Ophthalmol Vis Sci (2009) 1.14
In vivo confocal microscopy of the ocular surface. Ocul Surf (2006) 1.14
Novel production of interleukin-1 receptor antagonist peptides in normal human cornea. J Clin Invest (1995) 1.13
Development and validation of a short global dry eye symptom index. Ocul Surf (2007) 1.12
Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-alpha and IL-6 by human monocytes. J Immunol (2005) 1.09
Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency. Ophthalmology (1999) 1.09
Human tear film electrolyte concentrations in health and dry-eye disease. Int Ophthalmol Clin (1994) 1.08
Distinctive expression of chemokines and transforming growth factor-beta signaling in human arterial endothelium during atherosclerosis. Am J Pathol (2007) 1.03
Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjögren's syndrome. Can J Ophthalmol (2004) 1.02
Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis. Arthritis Rheum (2006) 1.02
Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. Allergy (2009) 0.99
Tear osmolarity. Ocul Surf (2006) 0.98
A comparative study to assess the clinical use of Fluorescein Meniscus Time (FMT) with Tear Break up Time (TBUT) and Schirmer's tests (ST) in the diagnosis of dry eyes. Eye (Lond) (2002) 0.96
The height and radius of the tear meniscus and methods for examining these parameters. Cornea (2000) 0.95
Association study between the CX3CR1 gene and asthma. Genes Immun (2006) 0.94
Anticytokine therapy in neuropathic pain management. Expert Rev Neurother (2007) 0.93
Impression cytology: recent advances and applications in dry eye disease. Ocul Surf (2009) 0.92
Cytokine responses by conjunctival epithelial cells: an in vitro model of ocular inflammation. Cytokine (2008) 0.91
A new method for tear film stability analysis using videokeratography. Am J Ophthalmol (2003) 0.91
TGF-beta1, IL-1beta, and Th2 cytokines stimulate vascular endothelial growth factor production from conjunctival fibroblasts. Exp Eye Res (2005) 0.90
Exposure to a controlled adverse environment impairs the ocular surface of subjects with minimally symptomatic dry eye. Invest Ophthalmol Vis Sci (2007) 0.89
Tear osmolarity variation in the dry eye. Trans Am Ophthalmol Soc (1986) 0.88
Phenol red thread test vs Schirmer's test: a comparative study. Eye (Lond) (2005) 0.88
Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation. Rheumatology (Oxford) (2007) 0.87
Concordance between common dry eye diagnostic tests. Br J Ophthalmol (2008) 0.87
Diagnostic tests in patients with symptoms of keratoconjunctivitis sicca. Am J Ophthalmol (1988) 0.85
Optical aberrations and visual disturbances associated with dry eye. Ocul Surf (2006) 0.83
Immunopathogenesis of conjunctival remodelling in vernal keratoconjunctivitis. Eye (Lond) (2006) 0.83
The role of fractalkine as an accelerating factor on the autoimmune exocrinopathy in mice. Invest Ophthalmol Vis Sci (2009) 0.83
Association between high tear epidermal growth factor levels and corneal subepithelial fibrosis in dry eye conditions. Invest Ophthalmol Vis Sci (2009) 0.82
Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome. Blood (2006) 0.82
Quantitation of tear lysozyme levels in dry-eye disorders. Arch Ophthalmol (1983) 0.82
Increasing importance of dry eye syndrome and the ideal artificial tear: consensus views from a roundtable discussion. Curr Med Res Opin (2006) 0.81
Dry eye: an update on clinical diagnosis, management and promising new treatments. Clin Exp Optom (2002) 0.80
Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis (2007) 3.48
Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol (2008) 2.37
Desiccating stress induces T cell-mediated Sjögren's Syndrome-like lacrimal keratoconjunctivitis. J Immunol (2006) 2.33
Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res (2006) 2.27
Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci (2007) 2.09
A mouse model of keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci (2002) 1.73
Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci (2003) 1.72
Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest Ophthalmol Vis Sci (2006) 1.63
Rates and determinants of oral human papillomavirus infection in young men. Sex Transm Dis (2012) 1.48
Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. Invest Ophthalmol Vis Sci (2006) 1.46
Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J Proteome Res (2009) 1.36
Sensors of the innate immune system: their mode of action. Nat Rev Rheumatol (2009) 1.31
Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca. Cornea (2005) 1.31
Strain-related cytokine profiles on the murine ocular surface in response to desiccating stress. Cornea (2007) 1.31
Epithelial-immune cell interaction in dry eye. Cornea (2008) 1.27
Applications of nanoparticles in ophthalmology. Prog Retin Eye Res (2010) 1.27
Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production. Cornea (2008) 1.27
Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatology (Oxford) (2009) 1.26
Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf (2013) 1.25
Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva. Invest Ophthalmol Vis Sci (2003) 1.16
Cytokine and chemokine levels in tears from healthy subjects. Acta Ophthalmol (2010) 1.14
Ocular surface APCs are necessary for autoreactive T cell-mediated experimental autoimmune lacrimal keratoconjunctivitis. J Immunol (2011) 1.12
Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Invest Ophthalmol Vis Sci (2006) 1.11
Impression cytology of the ocular surface: a review. Exp Eye Res (2004) 1.11
ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice. Exp Eye Res (2004) 1.10
Desiccating stress induces CD4+ T-cell-mediated Sjögren's syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-γ. Am J Pathol (2011) 1.07
Characterization and short-term culture of cells recovered from human conjunctival epithelium by minimally invasive means. Mol Vis (2009) 1.02
NK cells promote Th-17 mediated corneal barrier disruption in dry eye. PLoS One (2012) 1.02
Sensors of the innate immune system: their link to rheumatic diseases. Nat Rev Rheumatol (2010) 1.00
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials (2006) 1.00
Desiccating environmental stress exacerbates autoimmune lacrimal keratoconjunctivitis in non-obese diabetic mice. J Autoimmun (2007) 0.97
A comparison of stem cell-related gene expression in the progenitor-rich limbal epithelium and the differentiating central corneal epithelium. Mol Vis (2011) 0.95
In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation. Invest Ophthalmol Vis Sci (2008) 0.95
Pharmacological cholinergic blockade stimulates inflammatory cytokine production and lymphocytic infiltration in the mouse lacrimal gland. Invest Ophthalmol Vis Sci (2011) 0.95
Immunoregulation on the ocular surface: 2nd Cullen Symposium. Ocul Surf (2009) 0.93
Development of genital warts after incident detection of human papillomavirus infection in young men. J Infect Dis (2010) 0.93
Intraocular inflammation as the main manifestation of Rickettsia conorii infection. Clin Ophthalmol (2011) 0.92
Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium. Ocul Surf (2005) 0.92
The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project. Ophthalmology (2012) 0.92
Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD). Curr Eye Res (2012) 0.92
Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium. Invest Ophthalmol Vis Sci (2005) 0.92
Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis. Invest Ophthalmol Vis Sci (2013) 0.92
Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo. Clin Exp Allergy (2007) 0.91
Surgical outcomes of uveitic glaucoma. J Ophthalmic Inflamm Infect (2010) 0.91
Stress-activated protein kinase signaling pathways in dry eye and ocular surface disease. Ocul Surf (2005) 0.91
Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca. PLoS One (2011) 0.91
Spontaneous autoimmune dacryoadenitis in aged CD25KO mice. Am J Pathol (2010) 0.91
Cytokine responses by conjunctival epithelial cells: an in vitro model of ocular inflammation. Cytokine (2008) 0.91
Refractive stabilization and corneal swelling after cataract surgery. Optom Vis Sci (2013) 0.91
Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease. Invest Ophthalmol Vis Sci (2013) 0.90
Ocular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndrome. Invest Ophthalmol Vis Sci (2011) 0.90
Cat-scratch disease (ocular bartonellosis) presenting as bilateral recurrent iridocyclitis. Clin Infect Dis (2005) 0.90
Exposure to a controlled adverse environment impairs the ocular surface of subjects with minimally symptomatic dry eye. Invest Ophthalmol Vis Sci (2007) 0.89
Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells. Mol Vis (2011) 0.89
Evaluation of ocular surface inflammation in the presence of dry eye and allergic conjunctival disease. Ocul Surf (2005) 0.88
Autoantibodies contribute to the immunopathogenesis of experimental dry eye disease. Invest Ophthalmol Vis Sci (2012) 0.87
Circumcision and acquisition of human papillomavirus infection in young men. Sex Transm Dis (2011) 0.87
Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis. Arch Ophthalmol (2006) 0.87
In vitro simulation of corneal epithelium microenvironment induces a corneal epithelial-like cell phenotype from human adipose tissue mesenchymal stem cells. Curr Eye Res (2013) 0.87
The value of simple microbiological studies for on-site screening of acute neonatal conjunctivitis in Angola. J Ophthalmic Inflamm Infect (2014) 0.87
Macular edema as the only ocular finding of tuberculosis. Am J Ophthalmol (2004) 0.87
Molecular and cellular biomarkers in dry eye disease and ocular allergy. Curr Opin Allergy Clin Immunol (2012) 0.85
Effect of TGF-β on ocular surface epithelial cells. Exp Eye Res (2012) 0.84
Cleavage of functional IL-2 receptor alpha chain (CD25) from murine corneal and conjunctival epithelia by MMP-9. J Inflamm (Lond) (2009) 0.84
Human epithelium from conjunctival impression cytology expresses MUC7 mucin gene. Cornea (2003) 0.83
Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles. Cornea (2010) 0.83
Activation of MAPK signaling pathway and NF-kappaB activation in pterygium and ipsilateral pterygium-free conjunctival specimens. Invest Ophthalmol Vis Sci (2011) 0.83
Comparison of gene expression profiles of conjunctival cell lines with primary cultured conjunctival epithelial cells and human conjunctival tissue. Gene Expr (2009) 0.83
Conjunctival mucin mRNA expression in contact lens wear. Optom Vis Sci (2009) 0.83
Genetically engineered elastin-like polymer as a substratum to culture cells from the ocular surface. Curr Eye Res (2009) 0.83
Multimodal Imaging in Acute Posterior Multifocal Placoid Pigment Epitheliopathy Demonstrating Obstruction of the Choriocapillaris. Ophthalmic Surg Lasers Imaging Retina (2016) 0.82
Mitochondrial permeability transition pore in inflammatory apoptosis of human conjunctival epithelial cells and T cells: effect of cyclosporin A. Invest Ophthalmol Vis Sci (2013) 0.82
Neurogenic inflammation: a first line of defense for the ocular surface. Ocul Surf (2005) 0.82
Characterization by Belmonte's gas esthesiometer of mechanical, chemical, and thermal corneal sensitivity thresholds in a normal population. Invest Ophthalmol Vis Sci (2012) 0.82